BESPONSA vs LEUKINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. BESPONSA and LEUKINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BESPONSA	LEUKINE
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	INOTUZUMAB OZOGAMICIN	SARGRAMOSTIM
Manufacturer	Wyeth Pharms Inc	Berlex Labs
Dosage forms	Injectable	Injectable
Drug class	Cd22-Directed Immunoconjugate	Leukocyte Growth Factor
Boxed warning	Boxed warning	None
Treats	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Breast Neoplasms, Hodgkin Disease, Non-Hodgkin Lymphoma

besponsa leukine

Rating

New

Pharmacy pays

—

Type

Active ingredient

INOTUZUMAB OZOGAMICIN

SARGRAMOSTIM

Manufacturer

Wyeth Pharms Inc

Berlex Labs

Dosage forms

Injectable

Drug class

Cd22-Directed Immunoconjugate

Leukocyte Growth Factor

Boxed warning

None

Treats

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Breast Neoplasms, Hodgkin Disease, Non-Hodgkin Lymphoma

Frequently asked questions

What is the difference between Besponsa and Leukine?

Besponsa contains Inotuzumab Ozogamicin, while Leukine contains Sargramostim — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.